01 March 2005 : Original article
Segregation of the marker chromosome der(20) in the sperm of a male with karyotype 46,XY[961/ 47,XY+mar[4].
Ewa Wiland, Małgorzata Jarmuż, Maciej KurpiszMed Sci Monit 2005; 11(3): CS9-15 :: ID: 15392
Abstract
BACKGROUND: The influence of the marker chromosome on reproductive failure is difficult to assess, especially in the case of low-rate mosaicism. The aim of our work was to examine the meiotic segregation of the marker chromosome der(20) in the sperm of a normal male whose wife had experienced three miscarriages, and therefore to determine whether there occurred a gametogenic tissue-specific mosaicism. MATERIAL/METHODS: The proband was a phenotypically normal 35-year-old man, referred for pre-conceptional counseling after his wife had experienced three miscarriages. Chromosome cytogenetic analysis was performed on peripheral blood lymphocytes using routine protocols. Sperm chromosome complements were obtained after penetration of zona-free hamster oocytes. Dual-color FISH analysis was performed using directly labeled probes identifying X, Y, 9 and 20 chromosomes. RESULTS: A small marker chromosome der(20) was identified in 4% of the proband's lymphocytes and 8.25% of his sperm, which indicated mosaicism among the gametogenic cells, in which the proportion of cells containing the der(20) marker may reach a minimum of approx. 16%. CONCLUSIONS: In this case, we addressed a problem whether a revealed marker der(20) was the cause of reproductive failure or just a coincidental finding. In our view, each case of low-rate mosaicism of the marker chromosome should be individually assessed.
Keywords: Chromosome Segregation, Genetic Markers, In Situ Hybridization, Fluorescence, Karyotyping, Lymphocytes - cytology, Meiosis, Mosaicism, Spermatozoa - cytology, Chromosome Segregation, Genetic Markers, In Situ Hybridization, Fluorescence, Karyotyping, Lymphocytes - cytology, Meiosis, Mosaicism, Spermatozoa - cytology
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952